Cargando…

Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy

Cancer immunotherapy, which suppresses cancer progression by activating the anti-cancer immunity of patients, shows utility in treating multiple types of cancers. Immunogenic cell death (ICD) induced by most clinical treatment modalities plays a critical role in promoting cancer immunotherapy by rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yajie, Feng, Xiangru, Wan, Chao, Lovell, Jonathan F., Jin, Honglin, Ding, Jianxun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shenyang Pharmaceutical University 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105413/ https://www.ncbi.nlm.nih.gov/pubmed/33995609 http://dx.doi.org/10.1016/j.ajps.2020.05.004

Ejemplares similares

The role of immunogenic cell death in gastrointestinal cancer immunotherapy (Review)
por: Songjang, Worawat, et al.
Publicado: (2021)

Immunogenic cell death in cancer immunotherapy
por: Choi, Minji, et al.
Publicado: (2023)

Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors
por: Qi, Jing, et al.
Publicado: (2021)

Disease Immunotherapy: Immunomodulatory Nanosystems (Adv. Sci. 17/2019)
por: Feng, Xiangru, et al.
Publicado: (2019)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano-del Valle, Alfonso, et al.
Publicado: (2019)

The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer
por: Zhao, Rongling, et al.
Publicado: (2023)

Role of neuronal gap junctions in NMDA receptor-mediated excitotoxicity and ischemic neuronal death
por: Belousov, Andrei B., et al.
Publicado: (2016)

Osteoimmunity-regulating biomaterials promote bone regeneration
por: Liu, Zongtai, et al.
Publicado: (2023)

Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma
por: Zong, Yuan, et al.
Publicado: (2023)

Calcium ion nanomodulators for mitochondria-targeted multimodal cancer therapy
por: Zheng, Pan, et al.
Publicado: (2022)

Nanoantidotes: A Detoxification System More Applicable to Clinical Practice
por: Yang, Jiazhen, et al.
Publicado: (2023)

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Maes, Ken, et al.
Publicado: (2019)

Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
por: Palanivelu, Lalitha, et al.
Publicado: (2023)

Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy
por: Cruickshank, Brianne, et al.
Publicado: (2018)

Differences in the immunogenicity of engineered circular RNAs
por: Tai, Justin, et al.
Publicado: (2023)

Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
por: Ma, Jing, et al.
Publicado: (2020)

Is there a role for immunotherapy in HER2-positive breast cancer?
por: Holgado, Esther, et al.
Publicado: (2018)

Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy
por: Catanzaro, Elena, et al.
Publicado: (2022)

Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano Del Valle, Alfonso, et al.
Publicado: (2019)

Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy
por: Guo, Yichen, et al.
Publicado: (2023)

The role of neutrophil death in chronic inflammation and cancer
por: Brostjan, Christine, et al.
Publicado: (2020)

Is the Host Viral Response and the Immunogenicity of Vaccines Altered in Pregnancy?
por: Saeed, Zainab, et al.
Publicado: (2020)

Immunogenicity in Clinical Practice and Drug Development: When is it Significant?
por: Shakhnovich, Valentina, et al.
Publicado: (2019)

Nanomedicine sheds new light on cancer immunotherapy
por: Yu, Yingying, et al.
Publicado: (2023)

Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With Melanoma
por: de Greef, R, et al.
Publicado: (2016)

Immune dysregulation in extranodal NK/T cell lymphomas: potential roles in pathogenesis and immunotherapy
por: Polprasert, Chantana, et al.
Publicado: (2021)

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
por: Adkins, Irena, et al.
Publicado: (2015)

Gold Nanoparticles Enhance the Ability of Radiotherapy to Induce Immunogenic Cell Death in Glioblastoma
por: He, Chen, et al.
Publicado: (2023)

Single-Cell Sequencing in Rheumatic Diseases: New Insights from the Perspective of the Cell Type
por: Ding, Liqing, et al.
Publicado: (2022)

Identification of Immunogenic Cell Death-Related Signature for Glioma to Predict Survival and Response to Immunotherapy
por: Sun, Zhiqiang, et al.
Publicado: (2022)

Role of P2X(7) receptors in neuronal death in the retina
por: Sugiyama, Tetsuya
Publicado: (2014)

The promise of immunotherapy in genitourinary malignancies
por: Zhang, Tian, et al.
Publicado: (2018)

CXCR6-based immunotherapy in autoimmune, cancer and inflammatory infliction
por: Li, Tingting, et al.
Publicado: (2022)

A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins
por: Kierzek, Andrzej M., et al.
Publicado: (2019)

Immunogenic cell death-related long noncoding RNA influences immunotherapy against lung adenocarcinoma
por: SUN, DONGJIE, et al.
Publicado: (2023)

Gaps in allergen immunotherapy administration and subcutaneous allergen immunotherapy dose adjustment schedules: Need for prospective data
por: Larenas-Linnemann, Désirée Erlinda, et al.
Publicado: (2020)

Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives
por: Wu, Zimei, et al.
Publicado: (2021)

Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
por: Lu, Jianqin, et al.
Publicado: (2017)

Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
por: Gao, Jing, et al.
Publicado: (2020)

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
por: Li, Zhilin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0nothpfo9p00cbksdq01gq1549